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ABSTRACT
Introduction: In recent years researchers have
reported deficits in the quality of care provided
to patients with rheumatoid arthritis (RA),
including low rates of performance on quality
measures. We sought to determine the
influence of a quality improvement (QI)
continuing education program on
rheumatologists’ performance on national
quality measures for RA, along with other
measures aligned with National Quality
Strategy priorities. Performance was assessed
through baseline and post-education chart
audits.
Methods: Twenty community-based
rheumatologists across the United States were
recruited to participate in the QI education
program and chart audits. Charts were
retrospectively audited before (n = 160 charts)
and after (n = 160 charts) the rheumatologists
participated in a series of accredited QI-focused
educational activities that included private
audit feedback, small-group webinars, and
online- and mobile-accessible print and video
activities. The charts were audited for patient
demographics and the rheumatologists’
documented performance on the 6 quality
measures for RA included in the Physician
Quality Reporting System (PQRS). In addition,
charts were abstracted for documentation of
patient counseling about medication benefits/
risks and adherence, lifestyle modifications, and
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quality of life; assessment of RA medication side
effects; and assessment of RA medication
adherence.
Results: Mean rates of documented
performance on 4 of the 6 PQRS measures for
RA were significantly higher in the
post-education versus baseline charts (absolute
increases ranged from 9 to 24% of patient
charts). In addition, after the intervention,
significantly higher mean rates were observed
for patient counseling about medications and
quality of life, and for assessments of
medication side effects and adherence
(absolute increases ranged from 9 to 40% of
patient charts).
Conclusion: This pragmatic study provides
preliminary evidence for the positive influence
of QI-focused education in helping
rheumatologists improve performance on
national quality measures for RA.
Keywords: Chart audit; Continuing medical
education; Physician Quality Reporting
System; Quality improvement; Quality
measures; Rheumatoid arthritis
INTRODUCTION
Over the past decade, research examining the
quality of care provided to patients with
rheumatoid arthritis (RA) has indicated
notable deficits, including low or variable rates
of guideline-directed prescription of
disease-modifying antirheumatic drugs
(DMARDs) and vaccinations [1–5]. Evidence
suggesting gaps in care led to the development
of tools to monitor and improve the quality of
care for patients with RA [4, 6]. Through a
collaborative project that began nearly a decade
ago, the American College of Rheumatology
(ACR) worked with the American Medical
Association’s Physician Consortium for
Performance Improvement to develop a set of
6 process-based quality measures for RA [6].
These measures are included in the Centers for
Medicare and Medicaid Services (CMS)
Physician Quality Reporting System (PQRS) [7].
The RA measures comprise DMARD
prescription, tuberculosis (TB) screening
within 6 months prior to initiation of a new
biologic medication, disease activity assessment
and classification, functional status assessment,
prognosis assessment and classification, and
glucocorticoid management.
Designed to improve the quality,
accountability, and transparency of healthcare,
the PQRS program originally provided incentive
payments for eligible healthcare professionals
(those who received payments under the
Medicare Physician Fee Schedule) who met
criteria for reporting quality measures. As of
2015, the program imposes increasing
reimbursement penalties for eligible
professionals who have not reported PQRS
measure data according to CMS requirements
[8].
The terminology, principles, and
implementation methods of quality
improvement (QI) have not historically been
taught in United States undergraduate and
graduate medical schools. For practicing
physicians, most QI education and training
programs are based in academic medical
centers and large health systems [9]. In all
settings, however, physicians are currently
responding to new requirements for
participation in QI programs and reporting
quality measures for accountability and
value-based payment incentives. To realize the
potential for improving the quality of
healthcare, continuing education may be a key
strategy for addressing QI-related knowledge,
attitudinal, and practice gaps. We developed
and provided continuing education activities
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designed to support community-based
rheumatologists in improving performance on
PQRS quality measures for RA and additional
measures for patient counseling and
assessments of medication side effects and
adherence, which are related to priorities of
the National Quality Strategy (NQS) [10]. To
assess the influence of the education, we
conducted baseline and post-education chart
audits and compared rates of documented
performance on these measures.
METHODS
The QI education program and outcomes study
were approved by an independent institutional
review board (Sterling IRB, Atlanta, GA; IRB ID
#4534). This article does not contain any new
studies with human or animal subjects
performed by any of the authors.
Physician Recruitment and Baseline
Chart Selection
Twenty community-based rheumatologists
were recruited to participate in the chart
audits and educational activities. Given
documented rheumatology workforce
shortages in the United States, we sought to
sample from states with adequate numbers of
rheumatologists for the study. Using Centers for
Disease Control and Prevention (CDC)
surveillance data, we identified states with
high ratios of rheumatologists to patients with
arthritis (CDC data do not distinguish numbers
of patients with rheumatoid arthritis or
osteoarthritis). From the states with the
highest ratios of rheumatologists to patients,
we identified and recruited participants through
internal or purchased lists of practicing
rheumatologists, whom we contacted by
postal mail, fax, or email. Rheumatologists
were enrolled in the order of their expressed
interest in the educational program and study.
We aimed to recruit approximately equal
numbers of rheumatologists from the
Northeast, South, Midwest, and West.
The study was designed to review 160
baseline charts of adult patients (aged 18 years
and older) who had a diagnosis of RA for at least
1 year (indicated by ICD-9 codes 714.0, 714.1,
714.2, or 714.81 from billing data) and at least 1
visit with the participating rheumatologist
between 12/1/2012 and 11/30/2013.
Administrative staff for each of the 20
rheumatologists selected an oversample of up
to 12 charts that met inclusion criteria, with the
goal of obtaining an average of 8 charts per
rheumatologist. This number was determined
partly by pragmatic considerations including
the limited time commitment that the practices
could devote to identifying charts and funding
restrictions.
Eligible charts were selected by reviewing
consecutive patients with the most recent office
visits, working backward from the index date of
11/30/2013. In the baseline period, 3 practices
provided fewer than the targeted 8 charts (n = 4,
6, and 7). The rheumatologists in these practices
were enrolled in the educational program; thus,
their charts were included in the analysis. To
compensate for these practices to reach the
targeted 160 charts for baseline review, we
included 9 charts from 7 other practices. These
practices were selected through a process that
balanced the number of charts from the 4
geographical regions.
Each practice received a $500 administrative
fee to reimburse costs for staff resources. This
fee, which comprised a $250 resource allocation
for each of the 2 chart abstraction periods
(baseline and post-education), covered costs
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for identifying and pulling patient charts based
on eligibility criteria, as well as coordinating
with the chart abstractors.
Baseline Retrospective Chart Abstraction
and Analysis
Charts that met inclusion criteria were
retrospectively abstracted by 1 of 4 trained
medical record reviewers. Paper charts were
made available for review onsite, or they were
copied and sent to the chart abstractors for
offsite review. Electronic charts were accessed
remotely or onsite based on the preference and
capability of the practice. The reviewers
completed their abstraction of baseline charts
between December 2013 and February 2014. To
assess inter-rater reliability, each reviewer
compared samples of their colleague’s charts
through an internal quality assurance process.
The assessment was based on numbers of chart
variables for which the reviewers agreed in their
abstraction.
The charts were abstracted for patient
demographics and the rheumatologists’
documented performance on the 6 quality
measures for RA included in the 2013 and
2014 PQRS programs (Table 1). In addition,
charts were abstracted for (1) documentation
of patient counseling about medication
benefits/risks and adherence, lifestyle
modifications, and quality of life; (2)
assessment of RA medication side effects; and
(3) assessment of RA medication adherence. For
the latter measure, charts were reviewed for
whether adherence was assessed (yes or no) and
for documentation of adherence status
(adherent or nonadherent). These counseling
and assessment measures are related to NQS
priorities for ensuring that patients are engaged
in their healthcare, improving communication,
promoting effective prevention and treatment
practices, or making care safer [10]. Through
structured chart review, each rheumatologist’s
performance on the measures was recorded for
analysis in Statistical Package for the Social
Sciences (SPSS, IBM Corporation, NY, USA),
version 22.
Educational Activities
After the baseline chart review, the
rheumatologists participated in a series of
educational activities that were accredited by
the Accreditation Council for Continuing
Medical Education. The first activity was an
online audit-feedback session (45 min), which
was presented individually to each
rheumatologist by a medical chart review
expert. During these sessions, each physician’s
baseline rates of performance on the PQRS
quality measures were presented and
compared with the de-identified mean rates of
the other 19 rheumatologists in the study. The
sessions were designed to support participants
in identifying areas for improvement, focusing
especially on measures for which baseline
performance rates were low. The presenter
engaged the participant in discussing barriers
to performing and documenting the quality
measures, as well as in identifying strategies for
improvement. In addition, the feedback
addressed the rheumatologist’s documentation
of the patient counseling measures as well as
medication side effects and adherence.
Within 4 weeks of the audit-feedback
activity, each rheumatologist participated in a
45-min webinar with 4 other peers in the
cohort. The 5 small-group webinars were led
by an expert rheumatologist who guided
discussions of strategies for improving
performance on RA quality measures. One of
the co-authors of this article (E. Ruderman)
served as faculty presenter for these webinars.
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The discussions addressed the evidence-based
rationale for applying the quality measures in
clinical practice; approaches to improving
patient assessment, treatment, and
management based on the measures; and
strategies for appropriately documenting
performance on the measures. To reinforce
learning, the educational program also
included a variety of online- and
mobile-accessible accredited activities in an RA
QI toolkit. These included a 10-page
monograph that presented the evidence-based
rationale for the quality measures as well as a
12-page monograph and a 30-min video
addressing interprofessional approaches to
achieving high standards for the quality of RA
care. The 20 rheumatologists’ participation in
the audit-feedback and small-group webinar
activities was confirmed through roll call. For
the 3 online and mobile-accessible activities, all
of the rheumatologists self-reported their
participation.
Post-Education Retrospective
Chart Abstraction and Analyses
Six months after each rheumatologist
completed the educational activities, follow-up
chart audits (n = 160) were conducted
according to the same methods described for
the baseline reviews. In each practice, charts
were identified for patients with RA who had at
Table 1 PQRS quality measures for RA
Measure 108: DMARD therapy
Percentage of patients who were prescribed, dispensed, or administered at least 1 ambulatory prescription for a
DMARD
Measure 176: TB screening
Percentage of patients who have documentation of a TB screening performed and results interpreted within 6 months
prior to receiving a first course of therapy using a biologic DMARD
Measure 177: periodic assessment of disease activity
Percentage of patients who have an assessment and classification of disease activity (using a standardized assessment
tool) within 12 months
Measure 178: functional status assessment
Percentage of patients for whom a functional status assessment was performed (using a standardized assessment tool) at
least once within 12 months
Measure 179: assessment and classification of disease prognosis
Percentage of patients who have an assessment and classification of disease prognosis at least once within 12 months
Measure 180: glucocorticoid management
Percentage of patients who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone
C10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid
management plan within 12 months
All measures apply to patients aged 18 years and older with a diagnosis of RA
DMARD disease-modifying antirheumatic drug, PQRS Physician Quality Reporting System, RA rheumatoid arthritis, TB
tuberculosis
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least 1 visit with their physician in the
post-education period. The number of
post-education charts was matched to each
rheumatologist’s number of baseline charts.
Between August and October 2014, the
post-education charts were retrospectively
abstracted for documentation of the PQRS
quality measures and NQS-related clinical
processes during the 6-month period following
each rheumatologist’s completion of the
educational activities.
Statistical Analysis
Using SPSS, Chi-square tests were performed to
analyze the differences between baseline and
post-education frequencies of chart
documentation for the PQRS quality measures
for RA and the additional measures for patient
counseling and assessments of medication side
effects and adherence. p values less than 0.05
were considered significant.
RESULTS
The 20 participating rheumatologists were
located in the Northeast (n = 6), South (n = 5),
Midwest (n = 4), and West (n = 5). They
reported treating an average of 41 patients
with RA per week. The analysis included 160
baseline charts (mean = 8 per physician;
range = 4–9) and 160 post-education charts
(mean = 8 per physician; range = 4–9). The
comparisons of samples of charts abstracted by
the 4 different reviewers indicated agreement
for at least 90% of chart variables.
As presented in Fig. 1, there were
significantly higher mean rates of performance
on 4 of the 6 PQRS quality measures for RA in
the post-education versus baseline charts. The
absolute percentage increases for these 4
measures were as follows: tuberculosis
screening before biologic DMARD therapy
(24%, p\0.001); assessment and classification
of disease activity (23%, p\0.001); assessment
of functional status (9%, p = 0.01); and
assessment and classification of disease
prognosis (23%, p = 0.005). At baseline, 99%
of patient charts indicated prescription of
DMARD therapy; adherence to this measure
was not significantly different in the
post-education charts. For the sixth PQRS
measure, documentation of a glucocorticoid
management plan, only 1 patient in the
post-education sample met the eligibility
requirement of prolonged high-dose
glucocorticoid therapy; thus, analysis for this
measure was precluded.
For 2 of the 3 patient counseling measures
and for assessments of side effects and
medication adherence, there were significantly
higher mean rates of post-education versus
baseline chart documentation (Fig. 2). The
absolute percentage increases for these 4
measures were as follows: counseling about
medication (9%, p = 0.02); counseling about
quality of life (17%, p = 0.01); assessment of
medication side effects (22%, p\0.001); and
assessment of medication adherence (40%,
p\0.001). The proportion of charts indicating
that patients were adherent to their
medications was significantly greater in the
post-education (82%) versus baseline (48%)
review (p\0.001). For counseling about
lifestyle modifications, the mean percentage
increase after education did not reach
statistical significance (7%, p = 0.06).
DISCUSSION
Previous reports of suboptimal performance on
quality measures for RA have motivated leaders
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in the rheumatology community to call for
programs to improve the quality of RA patient
care [4, 6]. This pragmatic study provides
preliminary evidence for a positive influence
of accredited education on improving
performance on PQRS quality measures for RA
and on additional measures aligned with NQS
priorities. To our knowledge, this is the first
99
18
40
74
31
97
42
63
83
54
0
10
20
30
40
50
60
70
80
90
100
DMARD therapy TB screening Disease activity
assessment and
classification
Functional status
assessment
Disease prognosis
assessment and
classification
Pr
op
or
tio
n 
of
 D
oc
um
en
te
d 
C
ha
rt
s 
(%
)
Baseline Post-Education
p = 0.005
p = 0.01
p < 0.001
p < 0.001
p = 0.25
Fig. 1 Baseline and post-education rates of performance on
PQRS quality measures for rheumatoid arthritis. For all
measures other than TB screening before initiating biologic
DMARD therapy, adherence rates were based on 160
baseline charts and 160 post-education charts. Analyses for
TB screening were based on charts of patients who, in
accordance with the quality measure, had received a first
course of therapy using a biologic DMARD (n = 71
baseline charts; n = 77 post-education charts). DMARD
disease-modifying antirheumatic drug, PQRS Physician
Quality Reporting System, TB tuberculosis
82
39
51
59
25
91
46
68
81
65
0
10
20
30
40
50
60
70
80
90
100
Counseling: Medication Counseling: Lifestyle
modifications
Counseling: Quality of
life
Side effects assessed Medication adherence
assessed
Pr
op
or
tio
n 
of
 D
oc
um
en
te
d 
C
ha
rt
s 
(%
)
Baseline (n =160) Post-Education (n = 160)
p < 0.001
p < 0.001
p = 0.01
p = 0.060
p = 0.020
Fig. 2 Baseline and
post-education rates
of patient counseling
and assessments of
medication side effects
and adherence
Rheumatol Ther (2015) 2:141–151 147
study to report on QI-focused educational
interventions for improving adherence to
these measures. In addition, the study is
unique in providing data on performance rates
for the full set of PQRS RA measures among
community-based rheumatologists.
With the exception of DMARD treatment,
baseline rates of documented performance on
the PQRS measures were low to moderate,
ranging from 18% for TB screening before
initiating a biologic DMARD to 74% for
functional status assessment. In an analysis of
the 2009 ACR Rheumatology Clinical Registry
(RCR), Kazi et al. reported considerably higher
rates of adherence to 5 quality measures among
240 rheumatology providers who submitted
data for 7806 patients with RA: assessment
and classification of disease activity (100%),
DMARD treatment (93%), TB screening (92%),
assessment of functional status (79%), and
assessment and classification of disease
prognosis (78%) [11]. One explanation for the
higher rates of adherence reported by Kazi et al.
is that the providers were self-selected members
of the RCR. In addition, one of the main goals
of this registry is to give providers a mechanism
with which to document and report PQRS
measures. In an analysis of 2005–2008 HEDIS
data for more than 90,000 RA patients enrolled
in Medicare managed care plans, Schmajuk
et al. found that 63% of the patients had
received a DMARD [5]. The authors reported
that DMARD receipt varied considerably across
patient groups, with the lowest rates reported
for older individuals, black patients, and
patients with low socioeconomic status. The
study focused on health system performance,
thus reflecting DMARD use across both
rheumatology and primary care practices.
Recently, Desai et al. reported a study
involving reviews of 438 charts of RA patients
in an academic medical center rheumatology
practice [12]. Assessment of disease activity and
functional status were documented in 29% and
75% of the charts, respectively.
Our findings indicate that a program of
quality-focused education was associated with
significant improvements in documented
performance on 4 of the 6 PQRS measures for
RA and on additionalmeasures involving patient
counseling and assessments of medication side
effects and adherence. For several measures the
improvements were substantial. However,
post-education performance rates indicate gaps
and room for improvement for most of the
measures, including assessment of disease
prognosis (54%), assessment of disease activity
(63%), TB screening before initiating a biologic
DMARD (42%), counseling for lifestyle
modifications (46%) and quality of life (68%),
and assessment of medication adherence (65%).
Our observations of the rheumatologists’
discussions during the audit-feedback and
small-group webinar sessions may offer insight
into the suboptimal post-education
performance rates. These discussions addressed
the barriers and challenges the physicians face
in aligning their practices with national quality
measures. For example, some participants
commented that the methods necessary to
assess and classify disease activity and
prognosis are time-consuming and more
appropriate for clinical trials than for office
visits. Regarding the measure of TB screening, a
common response from participants was that
their electronic health records lack structured
fields for recording this measure. Several
rheumatologists commented that, despite the
lack of documentation in their charts, they
always screen patients for TB before initiating
biologic DMARD treatment. These responses
reflect the need for adaptations of electronic
medical records to efficiently collect key quality
and safety data in a standardized manner.
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Several limitations of the study should be
considered in interpreting the results. Because
the endpoints were process-based quality
measures, the performance of the same
physicians was assessed using different patient
charts in the baseline and post-education
audits. This design afforded some control over
participant-related extraneous variables.
However, conclusions regarding the direct
effect of the educational interventions are
limited by the lack of a control group of
rheumatologists who did not participate in the
educational activities and whose charts were
audited over the same time periods. An
interrupted time series trial with a control
group would be a stronger design for more
reliably assessing whether improvements were
attributable to the education rather than to
secular trends.
Due to the rheumatologists’ gaps in
documenting patient characteristics, especially
classifications of disease activity, we were not
able to determine whether patients whose
charts were audited in the baseline and
post-education period were matched for
variables that might have influenced quality of
care. Other potentially confounding factors,
which may influence quality of care and,
therefore, should ideally be matched across
samples, include number of patient visits and
patients’ income, health literacy, and
comorbidities. Another limitation is that the
post-education follow-up period was only
6 months. A longer follow-up may have
resulted in higher post-education rates of
adherence to the quality measures; in contrast,
it is possible that performance on quality
measures may revert to baseline over time
without continual reinforcement. Finally, we
were not able to determine whether the changes
observed between the baseline and follow-up
period related directly to improving
performance on these quality measures or to
better chart documentation. However, chart
documentation is a critical element of the
ability to assess compliance with these
measures. Moreover, documentation of these
measures is essential for guiding care processes,
including evaluating treatment effectiveness,
informing treatment decisions, and providing
essential information to promote patient safety.
This pragmatic study was not designed to
determine the extent to which the different
educational activities influenced performance
on the quality measures. The continuing
education literature has indicated that
conventional formats, such as didactic lectures
and print media, generally do not lead to
persistent changes in complex physician
behaviors [13–17]. In a meta-analysis of 140
studies on chart audit and feedback as an
educational intervention for healthcare
professionals, the authors concluded that this
method can elicit small but meaningful
improvements in clinical performance [18].
The greatest improvements occur when
feedback is offered by a supervisor or respected
colleague and accompanied by specific goals or
action plans for quality improvement. We
designed the audit-feedback sessions and
small-group webinars accordingly.
As suggested by Saag et al., the connection
between process-based RA quality measures and
patient outcomes and, therefore, the rationale
for aligning clinical practice with the measures
can be established with evidence from clinical
trials and well-designed observational studies
[4]. The development of the PQRS quality
measures for RA was strongly influenced by
the 2008 ACR guidelines [6]. A recent study
reported that rheumatologists’ documentation
of PQRS measures for disease activity assessment
and functional status was not significantly
associated with 2-year radiographic
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progression [12]. However, as acknowledged by
the authors, this study was limited partly
because the rates of documenting the quality
measures were low and RA outcome measures
were not consistently defined. New studies are
thus needed to understand relationships
between process-based quality measures and
patient outcomes. The results of these studies
will guide revisions of current quality measures
and the development of new ones, including
outcomes-based measures of disease activity
and function [19]. Evolving value-based care
delivery models may pose some barriers
associated with extra time demands for
performing, documenting, and reporting
quality measures. Thus, new QI programs and
studies are needed to develop strategies for
facilitating workflow to enable quality-driven
care.
CONCLUSION
The present study provides preliminary
evidence for the potential for QI-focused
education to help rheumatologists align their
practices with evidence-based and consensus
quality measures. Additional research will be
necessary to identify and optimize educational
interventions that yield significant and
sustainable improvements in the quality of
care for patients with RA.
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